文献速递乳腺癌

数字乳腺断层合成与数字乳腺摄影在不同年龄和乳腺密度下与癌症检出率和召回率的关联

Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density.
PubMed 文献 · JAMA Oncol · 2019-01-01

该回顾性分析基于PROSPR联盟3个研究中心2011至2014年40至74岁女性的180340次筛查,比较数字乳腺断层合成(DBT)与数字乳腺摄影(DM)。DBT与更低的召回率(OR 0.64)和更高的癌症检出率(OR 1.41)相关,且检出更小、更多淋巴结阴性、HER2阴性的浸润癌;40至49岁女性获益最大。

要点

  • DBT筛查与更低的召回率(OR 0.64;95%CI 0.57-0.72;P<.001)和更高的癌症检出率(OR 1.41;95%CI 1.05-1.89;P=.02)相关。
  • DBT检出更小、更多淋巴结阴性、HER2阴性的浸润癌(73.7% vs 65.4%)。
  • 40至49岁女性癌症检出率提升最大,且预后不良癌症比例更低(25.0% vs 40.4%)。

核心结论

  • 筛查使用DBT与更高的特异度和更高的检出更好预后乳腺癌的比例相关。
  • 在40至49岁女性亚组中,常规DBT筛查可能具有有利的风险-获益比。

研究设计与样本

  • 研究类型为对前瞻性队列数据的回顾性分析,数据来自PROSPR联盟3个研究中心。
  • 纳入2011年1月1日至2014年9月30日期间接受DM和DBT筛查的40至74岁女性。
  • 共纳入96269名女性,年龄均值(标准差)为55.9(9.0)岁;DM组为56.4(9.0)岁,DBT组为54.6(8.9)岁。
  • 共分析180340次乳腺癌症筛查检查,其中129369次(71.7%)使用DM,50971次(28.3%)使用DBT。
  • 统计分析于2017年11月8日至2018年8月14日进行。

主要发现

  • DBT筛查检出更小、更多淋巴结阴性、HER2阴性的浸润癌(73/99名女性,73.7%)相比DM(276/422名女性,65.4%)。
  • 在所有年龄组中,即使按乳腺密度分层,DBT相比DM与更低的召回率(OR 0.64;95%CI 0.57-0.72;P<.001)和更高的癌症检出率(OR 1.41;95%CI 1.05-1.89;P=.02)相关。
  • 40至49岁女性中DBT的癌症检出率提升最大且向更小、淋巴结阴性浸润癌的偏移最明显。
  • 40至49岁非致密乳腺女性中,DBT的癌症检出率比DM每1000名女性高1.70;致密乳腺女性中,DBT的癌症检出率比DM每1000名女性高2.27。
  • 40至49岁女性中,DBT筛查的28例乳腺癌中7例(25.0%)被归类为预后不良,而DM筛查的47例乳腺癌中19例(40.4%)为预后不良。

关键数值与推荐

  • 召回率:DBT相比DM的OR为0.64(95%CI 0.57-0.72;P<.001)。
  • 癌症检出率:DBT相比DM的OR为1.41(95%CI 1.05-1.89;P=.02)。
  • 40至49岁非致密乳腺女性:DBT的癌症检出率比DM每1000名女性高1.70。
  • 40至49岁致密乳腺女性:DBT的癌症检出率比DM每1000名女性高2.27。
  • 40至49岁女性预后不良癌症比例:DBT组25.0%(7/28)vs DM组40.4%(19/47)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Breast cancer screening examinations using digital breast tomosynthesis (DBT) has been shown to be associated with decreased false-positive test results and increased breast cancer detection compared with digital mammography (DM). Little is known regarding the size and stage of breast cancer types detected and their association with age and breast density. OBJECTIVE: To determine whether screening examinations using DBT detect breast cancers that are associated with an improved prognosis and to compare the detection rates by patient age and breast density. DESIGN, SETTING, AND PARTICIPANTS: This retrospective analysis of prospective cohort data from 3 research centers in the Population-based Research Optimizing Screening Through Personalized Regimens (PROSPR) consortium included data of women aged 40 to 74 years who underwent screening examinations using DM and DBT from January 1, 2011, through September 30, 2014. Statistical analysis was performed from November 8, 2017, to August 14, 2018. EXPOSURES: Use of DBT as a supplement to DM at breast cancer screening examination. MAIN OUTCOMES AND MEASURES: Recall rate, cancer detection rate, positive predictive value, biopsy rate, and distribution of invasive cancer subtypes. RESULTS: Among 96 269 women (mean [SD] patient age for all examinations, 55.9 [9.0] years), patient age was 56.4 (9.0) years for DM and 54.6 (8.9) years for DBT. Of 180 340 breast cancer screening examinations, 129 369 examinations (71.7%) used DM and 50 971 examinations (28.3%) used DBT. Screening examination with DBT (73 of 99 women [73.7%]) was associated with the detection of smaller, more often node-negative, HER2-negative, invasive cancers compared with DM (276 of 422 women [65.4%]). Screening examination with DBT was also associated with lower recall (odds ratio, 0.64; 95% CI, 0.57-0.72; P < .001) and higher cancer detection (odds ratio, 1.41; 95% CI, 1.05-1.89; P = .02) compared with DM for all age groups even when stratified by breast density. The largest increase in cancer detection rate and the greatest shift toward smaller, node-negative invasive cancers detected with DBT was for women aged 40 to 49 years. For women aged 40 to 49 years with nondense breasts, the cancer detection rate for examinations using DBT was 1.70 per 1000 women higher compared with the rate using DM; for women with dense breasts, the cancer detection rate was 2.27 per 1000 women higher for DBT. For these younger women, screening with DBT was associated with only 7 of 28 breast cancers (25.0%) categorized as poor prognosis compared with 19 of 47 breast cancers (40.4%) when screening with DM. CONCLUSIONS AND RELEVANCE: The findings suggest that screening with DBT is associated with increased specificity and an increased proportion of breast cancers detected with better prognosis compared with DM. In the subgroup of women aged 40 to 49 years, routine DBT screening may have a favorable risk-benefit ratio.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Conant EF, Barlow WE, Herschorn SD, et al. Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density. JAMA Oncol. 2019. PMID: 30816931. doi:10.1001/jamaoncol.2018.7078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。